MGTX vs PRME: stock comparison and AI forecast
Meiragtx Holdings Plc (MGTX) and Prime Medicine, Inc. (PRME) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MGTX Meiragtx Holdings Plc
- Price
- $8.51 -12.1% · 6M
- Market Cap
- $817M
- P/E Ratio
- 11.1x
- Size
- small-cap
- AI Forecast
PRME Prime Medicine, Inc.
- Price
- $4.45 +42.9% · 6M
- Market Cap
- $807M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- MGTX and PRME have similar market capitalizations ($817M and $807M).
- Over the last six months PRME returned +42.9% and MGTX -12.1%.
- MGTX turns 19.8% of its revenue into net income, against -4678.6% for PRME.
- PRME carries 5.26 times debt per unit of equity, against 0.84 times for MGTX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MGTX | PRME |
|---|---|---|
| Market Cap | $817M | $807M |
| P/E Ratio | 11.05x | – |
| P/B Ratio | 3.79x | 20.27x |
| EPS | $0.77 | $-1.18 |
| Book Value/Share | $2.24 | $0.22 |
| Revenue/Share | $4.16 | – |
| FCF/Share | $0.11 | $-0.86 |
Profitability & Margins
| Metric | MGTX | PRME |
|---|---|---|
| ROE | 36.6% | -472.0% |
| ROA | 19.9% | -75.5% |
| ROIC | 54.4% | -90.4% |
| Operating Margin | 46.1% | -4893.4% |
| Net Margin | 19.8% | -4678.6% |
| EBT Margin | 44.0% | -4893.4% |
| Tax Rate | 1.3% | 0.0% |
Financial Health
| Metric | MGTX | PRME |
|---|---|---|
| Current Ratio | 3.76x | 3.05x |
| D/E Ratio | 0.84x | 5.26x |
| Financial Leverage | 1.84x | 6.26x |
| Interest Coverage | 69.7x | – |
| Working Capital | $160M | $65M |
Cash Flow
| Metric | MGTX | PRME |
|---|---|---|
| Operating Cash Flow | $14M | -$156M |
| Free Cash Flow | $10M | -$157M |
| Capital Spending | -$3M | -$800K |
| FCF/Sales | 2.6% | – |
| CapEx/Sales | 0.8% | – |
Operational Efficiency
| Metric | MGTX | PRME |
|---|---|---|
| Asset Turnover | 1.01x | – |
| Fixed Assets Turnover | 4.0x | – |
Income Statement
| Metric | MGTX | PRME |
|---|---|---|
| Total Revenue | $399M | – |
| Operating Income | $184M | -$197M |
| Net Income | $79M | -$188M |
| R&D Expense | $153M | $146M |
| SG&A Expense | $98M | – |
Dividend & Shareholder Information
| Metric | MGTX | PRME |
|---|---|---|
| Shares Outstanding | 96M | 181M |
MGTX vs PRME: stock comparison and AI forecast
Which is bigger, MGTX or PRME?
MGTX and PRME have similar market capitalizations ($817M and $807M).
Which stock performed better over the last six months, MGTX or PRME?
Over the last six months PRME returned +42.9% and MGTX -12.1%.
Which one does Intratio's AI model rank higher, MGTX or PRME?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.